Mobility Will Boost East European Science

The political and social tidal wave that recently swept over Eastern Europe is sure to change the lives of its scientists. Restructuring the centralized economies will probably make conditions worse before they get better, and that means government support for science may shrink. On the other hand, if investment from joint ventures with science-based companies in the West begins to flow in, scientists may find their laboratories filled with equipment they could never before afford, owing to the

Written byDavid Pendlebury
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The political and social tidal wave that recently swept over Eastern Europe is sure to change the lives of its scientists. Restructuring the centralized economies will probably make conditions worse before they get better, and that means government support for science may shrink. On the other hand, if investment from joint ventures with science-based companies in the West begins to flow in, scientists may find their laboratories filled with equipment they could never before afford, owing to the lack of hard currency.

There's one thing, however, that has never been lacking in Eastern Europe: scientific brainpower. A recent field-by-field analysis of scientific performance shows Czechoslovakia to be strong in chemistry; Hungary and Poland in mathematics; and East Germany in mathematics, engineering, and physics. Even the relatively weaker Romania and Bulgaria have their niches: chemistry for Romania, and mathematics and chemistry in Bulgaria (A. Schubert, W. Glänzel, T. Braun, Scientometrics, 16:3-478, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies